Image
|
Figure Caption
Fig. 1 Ergolide treatment significantly reduced UM/MUM cell viability. (A, B) Dose-response analysis and determination of IC50 of ergolide in OMM2.5 cells as 2.9 μM via the MTT assay. (C, D) Long-term survival of Mel285, Mel270 and OMM2.5 clones were significantly (****, adjusted p=0.0001) reduced in ergolide treated samples compared to vehicle control (N = 3). Statistical analysis performed using One-way ANOVA with Dunnett's Test for Multiple Comparisons.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Open Res Eur